Status:
WITHDRAWN
Cardiology Prevention in Systemic Lupus Erythematosus (SLE)
Lead Sponsor:
University of Pittsburgh
Collaborating Sponsors:
Arthritis Foundation
National Institutes of Health (NIH)
Conditions:
Systemic Lupus Erythematosus
Eligibility:
FEMALE
19+ years
Phase:
NA
Brief Summary
We propose a feasibility study of aggressive CV risk factor management directed by preventive cardiology compared to usual care. We will determine: 1) the efficacy of a preventive cardiology program c...
Detailed Description
We will recruit 30 eligible patients from the Lupus Center of Excellence outpatient clinic. Patients will either be randomized into a preventive cardiology program for aggressive treatment, or randomi...
Eligibility Criteria
Inclusion
- Definitive diagnosis of SLE
- \>18 years of age
- Followed by rheumatologists (not the investigator, Dr. Elliott) at the Lupus Center of Excellence
- Informed consent signed
- Effective form of birth control
Exclusion
- Prior cardiovascular disease history (MI, coronary angioplasty, coronary artery bypass graft, abnormal coronary angiography, abnormal nuclear or treadmill stress test)
- Prior evaluation by preventive cardiology
- Active cardiac issues
- Pregnancy, breastfeeding, or anticipating pregnancy in the next 2 years
Key Trial Info
Start Date :
November 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2009
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00610805
Start Date
November 1 2009
End Date
November 1 2009
Last Update
January 15 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Lupus Center of Excellence, Magee Womens Hospital, 300 Halket St, Suite 1750
Pittsburgh, Pennsylvania, United States, 15213
2
Clinical and Translational Research Center (CTRC), Montefiore Hospital, 6NE, 200 Lothrop St.
Pittsburgh, Pennsylvania, United States, 15261